Aurora Establishes New Subsidiary

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 25, 2015) - Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(WKN:A1C4WM)(OTC:PSNTF) ("Aurora" or the "Company") is pleased to announce the establishment of its new subsidiary, Australis Capital Inc. ("Australis"), a company focused on opportunities in the United States with respect to production, processing, extracting of derivatives and sale of both medicinal and recreational cannabis.

Further to the Company's news release dated March 18, 2015, it has retained the services of Electrum Partners, LLC, from Las Vegas, Nevada to assist in this process. In synergy with Aurora's market strategy, Electrum Partners, LLC specializes in providing consulting, development, and management services in emergent State-legal opportunities.

With the U.S. market still in its nascent phase, the Company believes its experience in the Canadian regulatory environment (implemented as the "Aurora Standard") has the potential for broad market defining impact.

Subject to regulatory and shareholder approvals, the Company intends to spin out Australis under a Plan of Arrangement under the Business Corporations Act (British Columbia) (the "Arrangement"), pursuant to which 100% of the outstanding common shares of Australis will be distributed to the holders of common shares of Aurora on a pro-rata basis. The directors of the Company believe that the creation of two separate public companies, one focused in Canada and one focused in the U.S., will enhance their respective business operations and provide holders of Aurora securities with diversified investment choices. The Company will announce the details of the Arrangement in due course. There can be no assurances or guarantees that the Arrangement will be completed.

On behalf of the Board of Directors,

AURORA CANNABIS INC.

Terry Booth, CEO

Caution Regarding Forward-Looking Information:

Certain statements in this press release constitute "forward looking" statements within the meaning of applicable Canadian securities legislation, which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as "plan", "expect", "intend", "may", "will", "believe", "anticipate" and other similar terminology.

These statements include, but are not limited to, the expectation that Aurora will be able to obtain medical and recreational licensing in the U.S. and operate as such as currently contemplated and that the Arrangement may be effected. These statements reflect management's current expectations regarding future events and operating performance and speak only as of the date of this press release. The forward- looking statements involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, the Company's ability to obtain financing to expand its operations, product demand, market and customer acceptance of the Company's current and future products and services, the ability of the Company to develop effective products and receive regulatory approvals of such products, competitive factors, general economic conditions, government regulations, the inability to obtain shareholder and regulatory approvals for the Arrangement, regulatory requirements and other customary conditions. The Company undertakes no obligation to update publicly or revise any forward looking information, whether a result of new information, future results or otherwise, except as required by law.

The CSE, securities commission or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.